{"?xml":{"@version":"1.0"},"edm:RDF":{"@xmlns:dc":"http://purl.org/dc/elements/1.1/","@xmlns:edm":"http://www.europeana.eu/schemas/edm/","@xmlns:wgs84_pos":"http://www.w3.org/2003/01/geo/wgs84_pos","@xmlns:foaf":"http://xmlns.com/foaf/0.1/","@xmlns:rdaGr2":"http://rdvocab.info/ElementsGr2","@xmlns:oai":"http://www.openarchives.org/OAI/2.0/","@xmlns:owl":"http://www.w3.org/2002/07/owl#","@xmlns:rdf":"http://www.w3.org/1999/02/22-rdf-syntax-ns#","@xmlns:ore":"http://www.openarchives.org/ore/terms/","@xmlns:skos":"http://www.w3.org/2004/02/skos/core#","@xmlns:dcterms":"http://purl.org/dc/terms/","edm:WebResource":[{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:doc-LMJO0IMA/61abc9be-7979-466d-b150-f16dd81a6aa4/PDF","dcterms:extent":"530 KB"},{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:doc-LMJO0IMA/87ff4818-b144-4ac8-a613-019e4162867d/TEXT","dcterms:extent":"18 KB"}],"edm:TimeSpan":{"@rdf:about":"1929-2026","edm:begin":{"@xml:lang":"en","#text":"1929"},"edm:end":{"@xml:lang":"en","#text":"2026"}},"edm:ProvidedCHO":{"@rdf:about":"URN:NBN:SI:doc-LMJO0IMA","dcterms:isPartOf":[{"@rdf:resource":"https://www.dlib.si/details/urn:nbn:si:spr-a30mfzkp"},{"@xml:lang":"sl","#text":"Zdravniški vestnik"}],"dcterms:issued":"2012","dc:creator":["Drnovšek-Olup, Brigita","Lavrič, Alenka"],"dc:format":[{"@xml:lang":"sl","#text":"letnik:81"},{"@xml:lang":"sl","#text":"str. I-83-I-88"},{"@xml:lang":"sl","#text":"številka:supl."}],"dc:identifier":["ISSN:1318-0347","COBISSID:294316","URN:URN:NBN:SI:doc-LMJO0IMA"],"dc:language":"sl","dc:publisher":{"@xml:lang":"sl","#text":"Slovensko zdravniško društvo"},"dc:subject":[{"@xml:lang":"sl","#text":"anti-VEGF"},{"@xml:lang":"sl","#text":"bevacizumab"},{"@xml:lang":"sl","#text":"pterigij"},{"@xml:lang":"sl","#text":"vaskularizacija"}],"dcterms:temporal":{"@rdf:resource":"1929-2026"},"dc:title":{"@xml:lang":"sl","#text":"Učinek podvezničnega bevacizumaba na pterigij| Efficiency of subconjunctival bevacizumab on pterygium|"},"dc:description":[{"@xml:lang":"sl","#text":"Background: To evaluate the effect and complications of subconjunctival bevacizumab (Avastin Ž) on primary and recurrent pterygium. Methods: This prospective study included sixteen patients with pterygium, who received subconjunctival injection of bevacizumab (1.25 mg/0,1 mL). Digital photographywas used to evaluate vascularization of pterygium at 1 week, 1 month and 6 months after injection. Results: Sixteen patients (9 men and 7 women), aged between 41 and 74 years, with pterygium were included in the study. The pterygium was primary in nine patients and recurrent in seven patients. A rapid regression of vascularisation of pterygium was noted one week after treatment in all patients treated with bevacizumab. The recurrence was observed in two patients 1 month and in ten patients 6 months after injection. No change of visual acuity was noted and no systemic or ocular adverse events were observed. Conclusions: Subconjunctival bevacizumab (AvastinŽ) was safe and effective in providing a short-term regression of conjunctival vessels in the pterygial bed"},{"@xml:lang":"sl","#text":"Izhodišča: Oceniti učinek in zaplete podvezničnega bevacizumaba (AvastinŽ) na primarni in ponavljajoči se pterigij. Metode: Prospektivna študija je vključevala 16 bolnikov s pterigijem, ki so prejeli injekcijo bevacizumaba podočesno veznico (1,25 mg/0,1 mL). Ožiljenost pterigija 1 teden, 1 mesec in 6mesecev po injekciji smo ocenili s primerjavo digitalnih fotografij. Rezultati: V študijo je bilo vključenih 16 bolnikov s pterigijem (9 moških in 7 žensk), starih med 41 in 74 let. Pterigij je bil primaren pri devetih bolnikih in ponavljajoči se pri 7 bolnikih. Pri vseh bolnikih, zdravljenih z bevacizumabom, smo opazili hitro pojenjanje ožiljenosti pterigija en teden po zdravljenju. Ponovitev vaskularizacije smo opazili pri dveh bolnikih 1 mesec in pri desetih bolnikih 6 mesecev po injekciji. Sprememb v vidni ostrini, sistemskih ali očesnih škodljivih učinkov nismo opazili. Zaključki: Podveznični bevacizumab (AvastinŽ) je bil varen in učinkovit pri kratkotrajni regresiji vezničnih žilic v pterigiju"}],"edm:type":"TEXT","dc:type":[{"@xml:lang":"sl","#text":"znanstveno časopisje"},{"@xml:lang":"en","#text":"journals"},{"@rdf:resource":"http://www.wikidata.org/entity/Q361785"}]},"ore:Aggregation":{"@rdf:about":"http://www.dlib.si/?URN=URN:NBN:SI:doc-LMJO0IMA","edm:aggregatedCHO":{"@rdf:resource":"URN:NBN:SI:doc-LMJO0IMA"},"edm:isShownBy":{"@rdf:resource":"http://www.dlib.si/stream/URN:NBN:SI:doc-LMJO0IMA/61abc9be-7979-466d-b150-f16dd81a6aa4/PDF"},"edm:rights":{"@rdf:resource":"http://creativecommons.org/licenses/by-nc/4.0/"},"edm:provider":"Slovenian National E-content Aggregator","edm:intermediateProvider":{"@xml:lang":"en","#text":"National and University Library of Slovenia"},"edm:dataProvider":{"@xml:lang":"sl","#text":"Slovensko zdravniško društvo"},"edm:object":{"@rdf:resource":"http://www.dlib.si/streamdb/URN:NBN:SI:doc-LMJO0IMA/maxi/edm"},"edm:isShownAt":{"@rdf:resource":"http://www.dlib.si/details/URN:NBN:SI:doc-LMJO0IMA"}}}}